Loading...
•
Jul 31, 2020
Avid Bioservices Q1 2021 Earnings Report
Reported a strong start to fiscal year 2021 with revenue of $25.4 million and net income of $4.7 million.
Key Takeaways
Avid Bioservices reported a strong start to fiscal year 2021, achieving revenues of $25.4 million and net income of $4.7 million. The company signed three new customers and project expansion orders with current customers for $20 million, ending the quarter with a backlog of $60 million.
Achieved revenues of $25.4 million for the first quarter of fiscal 2021.
Reported a net income of $4.7 million for the quarter.
Signed three new customers and project expansion orders with existing customers, totaling $20 million.
Ended the quarter with a backlog of $60 million.